[Form 4] AVIENT CORP Insider Trading Activity

Rhea-AI Filing Summary

Patricia Verduin, a director of Avient Corporation (AVNT), reported acquiring 1,192 shares of Avient common stock on 09/30/2025 at no cash price, increasing her beneficial ownership to 25,058 shares. The Form 4 was signed by Robert K. James as power of attorney on 10/02/2025. The filing identifies the transaction as a non-derivative acquisition by an insider and shows direct ownership following the reported purchase.

Positive

• Insider acquisition reported: Director Patricia Verduin acquired 1,192 shares on 09/30/2025, indicating additional insider alignment with the company.
• Clear beneficial ownership: Post-transaction beneficial ownership is disclosed as 25,058 shares, providing transparency about insider holdings.

Negative

• None.

Insights

Securities Analyst

TL;DR: Insider director purchased a modest number of shares, increasing direct stake to 25,058 shares; impact appears limited.

The Form 4 discloses a non-derivative acquisition of 1,192 Avient shares by director Patricia Verduin on 09/30/2025 reported via power of attorney on 10/02/2025. The transaction is coded as an acquisition with a reported price of $0, consistent with a stock award or similar grant rather than an open-market purchase; however, the form does not provide explanatory detail beyond the table. The post-transaction beneficial ownership of 25,058 shares represents the total direct holdings disclosed.

Corporate Governance Expert

TL;DR: Routine insider disclosure of a small, likely compensatory equity grant; no material governance signal.

The filing shows a director-level insider receiving 1,192 shares. The $0 price suggests the shares were granted or issued rather than bought, which is common for director compensation. There is no indication of derivative activity, pledging, or disposition. Given the size relative to typical director holdings and absence of additional context, this is a routine disclosure with limited material impact for investors.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Verduin Patricia

(Last) (First) (Middle)

AVIENT CORPORATION

33587 WALKER ROAD

(Street)

AVON LAKE OH 44012

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AVIENT CORP [ AVNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/30/2025		A		1,192	A	$0	25,058	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	By: /s/ Robert K. James, Power of Attorney for Patricia Verduin	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Patricia Verduin report on Form 4 for AVNT?

She reported a non-derivative acquisition of 1,192 shares of Avient common stock on 09/30/2025, bringing her beneficial ownership to 25,058 shares.

Was the transaction an open-market purchase or a grant for AVNT?

The Form 4 shows a reported price of $0, which is consistent with a stock grant or issuance rather than an open-market purchase; the form does not provide further explanation.

Who signed the Form 4 filing for Patricia Verduin?

The form was signed by Robert K. James as Power of Attorney for Patricia Verduin on 10/02/2025.

Does the Form 4 show any derivative or disposition activity for AVNT?

No. The filing contains only a non-derivative acquisition entry and does not report any derivative securities or dispositions.

How material is this insider transaction to investors in AVNT?

This appears to be a routine, small insider grant with limited materiality; the filing does not indicate a significant change in control or large economic impact.